PRO-C10
A fragment of the NC1 domain of type X collagen, enabling non-invasive monitoring of chondrocyte hypertrophy and cartilage matrix remodeling in osteoarthritis and inflammatory joint diseases.
Key features and values
- Quantifies type X collagen fragments associated with chondrocyte hypertrophy.
- Reflects cartilage matrix remodeling linked to osteoarthritis and inflammatory joint conditions.
- Provides a non-invasive measure of cartilage turnover dynamics.
- Supports monitoring of disease progression and response to therapies targeting cartilage degradation.
- Applicable in research on diseases characterized by aberrant cartilage remodeling.
- Facilitates evaluation of interventions aimed at modulating cartilage matrix degradation.
- Complements other biomarkers for a comprehensive assessment of joint tissue remodeling dynamics.
Description
The PRO-C10 biomarker assay measures specific fragments of the NC1 domain of type X collagen, serving as an indicator of chondrocyte hypertrophy and cartilage matrix remodeling. This non-invasive assay provides insights into cartilage turnover processes associated with osteoarthritis and inflammatory joint diseases. By quantifying type X collagen degradation products, the PRO-C10 assay aids in monitoring disease progression, evaluating treatment efficacy, and understanding the underlying mechanisms of cartilage degradation and remodeling. It serves as a valuable tool in research settings for assessing the dynamics of cartilage matrix turnover and chondrocyte activity.
Nordic Bioscience’s assays and services are research use only products and services and do not qualify for medical or diagnostic purposes.
